Member Info for Chris0123

There not their oops

We are rising as we do on good sentiment for the company's potential. This will in no way lessen the impact of a rise based on fact - the clinical hold being lifted. The wind will go stronger even as those in at 2 point something get out with 4 point something, their will be gusts of new investors to take over the sails & rigging and drive this share to a new world in biotechnology success. Good luck Hemo ship and all who sail in her.

Park benches will all be occupied by the shorters Pumpky

Anyone out there with a contact in New York. If so, we can we have Vlad tailed to see whether he pops into a liquor store for a crate of the very best Champagne. This might be the best early indicator that the FDA got back to him. Although, we wouldn't want to discover he bought one bottle of Rye Whiskey in a brown paper bag and is seen drinking it whilst walking out the liquor store. GLA

Haha puint nuted Investandpants thank yuu... now where is that "o" key!

It's a mute point Mr Jinx but I think someone else pointed out that Monday was a Public Holiday in the US and unlikely an RNS at 7 am on Tuesday was for a submission dropped at 2 am Tuesday with the FDA. So, logic tells us the envelope was dropped Friday before . A week. However, even the preceding days Vlad and his team will have been winding down from the re-submission as only external data to wait on. Ample time to devote to CBR alone.

I say mute point because I am sure Vlad has not been ignoring CBR progress and exclusively entrenched with Car T. It has been a long time since an official update on CBR so it is not unreasonable to expect an update of some description - now would be a good time.

It pained me to write this as your response was really just a tad pedantic and unnecessary. Too much good news coming to be falling out with anyone though - GLA to you and all.

Positive CBR news drop would be welcome right now. Vlad dropped the re-submission for Car T a week ago or so, had time to look at lab progress so a comforting update RNS on how CBR has progressed would do wonders. GLA

A few 1 million + buys would be nice before the close. It feels like that sort of day. GLA

The FDA & Hemo next contact may go something like this:

FDA: Vlad, it's Brad here, FDA.

Vlad: Hi Brad, been busy sorry. What can I do for you, I have just a couple of minutes respite from trying to save the world. from all sorts of ***t.

Brad: That envelope you dropped off the other day. Had a quick butcher's at it this morning over breakfast. Was gonna call you immediately about one of your findings but realised it was a just a jelly stain I had been trying to interpret.

Vlad: Yes, that was one of the grand kids messing with my submission. If you see a stickman, that's nothing to do with my FDA re-application either.

Brad: Anyway, whatever! Yep read through it, looks like you have done what you said you would do - except the jelly and stickman of course and you are good to go.

Vlad: That was quick!

Brad: You've got lives to save Vlad, best get on and do it.

Vlad: Happy days. No offence Brad but I hope I don't have to speak to you ever again.

Brad: None taken. Bye!

Vlad: Bye Brad you can buy me lunch some time. (Puts phone down)

Vlad under his breath "Now where is that little ***t who nearly cost me IND approval"

Probably slightly far-fetched! GLA

Great summary Haywain.

Dr Sandler has always stated that going clinical is an "inflection point" for the company. Definition of "inflection" - "a time of significant change in a situation; a turning point" - We all hope he is right but he has chosen that word for good reason. However, going forward with clinical trials becomes Prevails baby. If you need any additional comfort, their website is worth a read. They are there to monetize a life science product, so reading into that, they are there to monetize their own investment too and they are expert enough to know that cannot mean one tranche of investment. They will either assist in gaining outside investment or bung in more themselves. We all know we will need more money and Prevail have come into this partnership with eyes wide open and a clear understanding that this extra investment can be achieved given what Cart T can potentially achieve. GLA

Sorry Jaytee got your point now. Ehatever is out there and at whatever stage Hemo therapy fully patented.

Not AML it is ALL a different cancer.

JHFH, albeit inadvertently, I think that litany of differing date predictions for the lifting the clinical hold will serve the current investors well in helping to confuse the would be traders in their attempts to predict the same. GLA

Wednesday 7th February for me. I have chosen this date for 2 reasons firstly, Wednesday always draws a comment from HT so I kind of feel obligated to him. Secondly, on the 8th Jan I posted RNS submission to be within Jan and the CH lifted well within Feb so sticking with that. Hope I am wrong and it's in January. GLA

Itsthehopethatkills - getting FDA approval and all that is associated with that accolade is NOT "unchartered territory" for Prevail. Let yourself believe.

What happens to the SP today very much depends on what you have in your hand and at what price you got them for. There will be newbies who have seen the news and will hop in and hop out and even those new in since Christmas doing likewise. They have a short period within which to nail their colours to the mast. C'est la vie. CBR news may well come before the FDA news also. No one can be disappointed by the step announced today (shorters excluded) There were some people several weeks ago who believed there were testing issues in the background - but not after today. GLA

Is it me and my oversimplification, but does the SP have greater stability when the CEO is in the Lab compared to when he is at conferences. If so, let the science do the talking Sir and they will come to you. GLA

Haywain / JHFH I think you are spot on... announcement of deals held back until conference to make the big splash. Would be pure fantasy to think that all the deals announced, converged coincidentally this week. Companies of all types rush out developments/products/initiatives with a deal in tow to help sell their wares at conferences/exhibitions. Unfortunately the PQ run was all Hemogenyx could announce through an RNS around that time and we have all seen how that impacted even though it was a positive step. He would have preferred and was trying to get CH sorted in time but it was not to be. At least it shows some business acumen in trying to combine progress with investors types. That's the least we should expect. We will get there, hare and tortoise and all that! GLA all & get well whoever needs to around this time. (PS: We are all hungry Hemogenyx, time for a banquet not a morsel).

No, certainly not in my view SprintRS - I have explained my reasoning in my post dated 8/1/24. GLA

Thailand are reporting a 300% increase in Zika cases. This is one of the CBR targets being tested. This virus has a devastating impact on unborn babies in terms of deformities and brain development. Hemogenyx, it would be good to get some sort of update on CBR soon. Even better, to be at the forefront of providing a solution to multiple viruses. GLA